Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
The Cancer Genome Atlas Network recently cataloged recurrent genomic abnormalities in glioblastoma multiforme (GBM). We describe a robust gene expression-based molecular classification of GBM into Proneural, Neural, Classical, and Mesenchymal subtypes and integrate multidimensional genomic data to e...
Main Author: | Mesirov, Jill P. |
---|---|
Other Authors: | Koch Institute for Integrative Cancer Research at MIT |
Format: | Article |
Language: | en_US |
Published: |
Elsevier
2015
|
Online Access: | http://hdl.handle.net/1721.1/96039 |
Similar Items
-
XGBoost improves classification of MGMT promoter methylation status in IDH1 wildtype glioblastoma
by: Le, Nguyen Quoc Khanh, et al.
Published: (2021) -
EGFR Variant Heterogeneity in Glioblastoma Resolved through Single-Nucleus Sequencing
by: Francis, Joshua M., et al.
Published: (2016) -
Integrated regulatory models for inference of subtype‐specific susceptibilities in glioblastoma
by: Liu, Yunpeng, et al.
Published: (2022) -
Integrated regulatory models for inference of subtype‐specific susceptibilities in glioblastoma
by: Liu, Yunpeng, et al.
Published: (2021) -
Detection of Isocitrate Dehydrogenase (IDH-1), Epidermal Growth Factor Receptor (EGFR), P53 and C-erbB2/HER2 mutation in glial tumour
by: Azman, Nusaibah, et al.
Published: (2022)